Abbott Laboratories Share Price Börse Stuttgart
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.03 EUR | +0.21% |
|
0.00% | -24.69% |
| Market Cap | 161B 141B 130B 121B 228B 15,265B 233B 1,561B 605B 7,493B 603B 590B 26,077B | P/E 2026 * |
22.8x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 172B 151B 139B 130B 245B 16,376B 250B 1,674B 649B 8,038B 647B 633B 27,976B | EV / Sales 2026 * |
3.43x | EV / Sales 2027 * | 3.09x |
| Free-Float |
86.73% | Yield 2026 * |
2.76% | Yield 2027 * | 2.95% |
Last Transcript: Abbott Laboratories
| 1 week | +1.61% | ||
| Current month | +1.81% | ||
| 1 month | +7.36% | ||
| 3 months | -8.44% | ||
| 6 months | -23.33% | ||
| Current year | -23.33% |
| 1 week | 79.08 |  | 83.34 |
| 1 month | 74.04 | | 83.34 |
| 3 years | 69.64 | | 134.1 |
| 5 years | 69.64 | | 134.1 |
| 10 years | 34 | | 134.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | 0.00% | -29.76% | -18.05% | 161B | |
| +1.24% | -1.16% | -10.76% | -10.10% | 101B | |
| +1.92% | +1.39% | -2.34% | +49.88% | 56.12B | |
| -1.22% | -2.03% | +54.34% | +47.88% | 53.35B | |
| +1.04% | +3.47% | -13.94% | -42.09% | 42.13B | |
| +5.81% | +15.76% | - | - | 35.29B | |
| +2.24% | -1.28% | -17.61% | -46.42% | 26.57B | |
| +1.67% | +7.22% | +64.10% | -4.57% | 25.79B | |
| +0.82% | +2.48% | -12.51% | -5.64% | 20.69B | |
| +2.69% | +0.96% | -12.07% | -3.17% | 19.59B | |
| Average | +1.80% | +2.76% | +2.16% | -3.59% | 42.32B | |
| Weighted average by Cap. | +1.55% | +1.89% | -5.92% | -3.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.26B 44.13B 40.62B 37.85B 71.38B 4,778B 72.83B 489B 189B 2,345B 189B 185B 8,162B | 54.75B 48.07B 44.25B 41.23B 77.76B 5,205B 79.34B 532B 206B 2,555B 206B 201B 8,892B |
| Net income | 7.02B 6.16B 5.67B 5.29B 9.97B 667B 10.17B 68.22B 26.43B 328B 26.35B 25.78B 1,140B | 8.39B 7.37B 6.78B 6.32B 11.91B 798B 12.16B 81.55B 31.6B 392B 31.5B 30.82B 1,363B |
| Net Debt | 11.69B 10.26B 9.45B 8.8B 16.6B 1,111B 16.94B 114B 44.02B 545B 43.89B 42.94B 1,898B | 8.86B 7.78B 7.16B 6.67B 12.58B 842B 12.83B 86.09B 33.36B 413B 33.26B 32.54B 1,438B |
| Date | Price | Change |
|---|---|---|
| 02/07/26 | €80.68 | -0.22% |
| 01/07/26 | €80.86 | +1.81% |
| 30/06/26 | €79.42 | -2.12% |
| 29/06/26 | €81.14 | -1.60% |
| 26/06/26 | €82.46 | +0.78% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
